Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.

Autor: Heyes J, Catherall EJ, Cockburn A
Jazyk: angličtina
Zdroj: Cancer chemotherapy reports [Cancer Chemother Rep] 1973 Sep-Oct; Vol. 57 (3), pp. 263-8.
Databáze: MEDLINE